PPARGC1A and diabetes mellitus: Facilitate Nrf2-metallothionein pathway through AMPK/AKT/GSK-3β signaling;Mitigate the diabetes-induced inhibition of LKB1/AMPK/sirtuin 1/PGC-1α signaling